COMP <GO>
MAS vs TMO // REVENUE GROWTH (YOY)
Masco Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MAS 7
— TMO 8
▲ REVENUE GROWTH (YOY) LEADER: TMO
LAST: $80.64 (+0.57%) • MKT CAP: $15.46B
revenue-growth
-3.40%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MAS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.40% | 41.00% | -5.60 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 46.70% | 9.30% | +37.40 | MAS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.5x | 30.4x | -18.90 | MAS | /valuation <GO> |
| Free Cash Flow Yield | 4.41% | 2.40% | +2.01 | MAS | /fcf-yield <GO> |
| Operating Margin | 16.50% | 17.40% | -0.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.70% | 15.10% | -4.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -3.40% | 3.90% | -7.30 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.69% | 0.24% | +1.45 | MAS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.16 | 4.50 | -0.34 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | MAS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.4 | 59.1 | +14.24 | MAS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.94 | -0.03 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.8x | 36.3x | -18.50 | MAS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.46B | $262.22B | -$246.76B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MAS REV | TMO REV | MAS GROSS % | TMO GROSS % | MAS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.56B | $44.56B | 35.4% | 44.0% | $681.7M | $6.29B |
| FY 2024 | $7.83B | $42.88B | 36.2% | 44.0% | $722.7M | $7.27B |
| FY 2023 | $7.97B | $42.86B | 44.0% | 44.0% | $1.05B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MAS // BETA 0.91
TMO // BETA 0.94